EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules

Giulia Tomaino iD, Camilla Pantaleoni, Annalisa D'Urzo, Carlo Santambrogio iD, Filippo Testa iD, Matilde Ciprandi, Davide Cotugno, Gianni Frascotti iD, Marco Vanoni iD, Paolo Tortora iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25126629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Giulia Tomaino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy. Hauptthemen laut MEDLINE: Vault Ribonucleoprotein Particles, Nanoparticles, Trastuzumab. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (PRIN 2017: "Development of a biotechnological nanoparticle platform for the delivery of antitumor therapies using…, Italian Ministry of University and Research, CHRONOS (Chronical Multifactorial Disorders Explored by Novel Integrated Strategies).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaults are eukaryotic ribonucleoproteins consisting of 78 copies of the major vault protein (MVP), which assemble into a nanoparticle with an about 60 nm volume-based size, enclosing other proteins and RNAs. Regardless of their physiological role(s), vaults represent ideal, natural hollow nanoparticles, which are produced by the assembly of the sole MVP. Here, we have expressed in Komagataella phaffi and purified an MVP variant carrying a C-terminal Z peptide (vault-Z), which can tightly bind an antibody’s Fc portion, in view of targeted delivery. Via surface plasmon resonance analysis, we could determine a 2.5 nM affinity to the monoclonal antibody Trastuzumab (Tz)/vault-Z 1:1 interaction. Then, we characterized the in-solution interaction via co-incubation, ultracentrifugation, and analysis of the pelleted proteins. This showed virtually irreversible binding up to an at least 10:1 Tz/vault-Z ratio. As a proof of concept, we labeled the Fc portion of Tz with a fluorophore and conjugated it with the nanoparticle, along with either Tz or Cetuximab, another monoclonal antibody. Thus, we could demonstrate antibody-dependent, selective uptake by the SKBR3 and MDA-MB 231 breast cancer cell lines. These investigations provide a novel, flexible technological platform that significantly extends vault-Z’s applications, in that it can be stably conjugated with finely adjusted amounts of antibodies as well as of other molecules, such as fluorophores, cell-targeting peptides, or drugs, using the Fc portion as a scaffold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vault Ribonucleoprotein ParticlesNanoparticlesTrastuzumabHumansCell Line, TumorCetuximabAntibodies, MonoclonalImmunoconjugatesMajor Vault Protein

Stichwörter der Autor:innen

Fc antibody portionKomagataella phaffii expression systemantibody-mediated targetingliquid chromatography/mass spectrometrymajor vault proteinsurface plasmon resonancevault nanoparticle

Substanzen

Vault Ribonucleoprotein ParticlesTrastuzumabCetuximabAntibodies, MonoclonalImmunoconjugatesMajor Vault Protein

Autor:innen und Institutionen

  • Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy.
  • ISBE-SYSBIO Centre for Systems Biology, 20126 Milan, Italy.

ORCID-Profile: Giulia Tomaino, Carlo Santambrogio, Filippo Testa, Gianni Frascotti, Marco Vanoni, Paolo Tortora

Förderung

  • Italian Ministry of University and Research (PRIN 2017: "Development of a biotechnological nanoparticle platform for the delivery of antitumor therapies using…
  • Italian Ministry of University and Research
  • CHRONOS (Chronical Multifactorial Disorders Explored by Novel Integrated Strategies)

Zitieren

APA

Tomaino, G., Pantaleoni, C., D'Urzo, A., Santambrogio, C., Testa, F., Ciprandi, M., Cotugno, D., Frascotti, G., Vanoni, M., & Tortora, P. (2024). An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126629

Vancouver

Tomaino G, Pantaleoni C, D'Urzo A, Santambrogio C, Testa F, Ciprandi M, et al. An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126629

BibTeX
@article{Tomaino2024,
  author = {Tomaino, Giulia and Pantaleoni, Camilla and D'Urzo, Annalisa and Santambrogio, Carlo and Testa, Filippo and Ciprandi, Matilde and Cotugno, Davide and Frascotti, Gianni and Vanoni, Marco and Tortora, Paolo},
  title = {An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25126629}
}
Kostenlos starten →